Promaxo, a medical technology pioneer, announced the closure of an $8 million financing round backed by super angels and strategic investors.
The company plans to allocate these funds toward accelerating the clinical launch of its in-office MRI platform targeting urology practices. The investment will also support development of a robotic-guidance system designed for live MRI interventions in physician offices, with the goal of improving patient care quality and experience.
“Promaxo’s MRI platform is consistently being recognized as a breakthrough technology by healthcare and industry professionals,” stated Amit Vohra, the company’s President and CEO. “The funding will help propel our in-office MRI to market and advance our product pipeline.”
Promaxo develops customer-focused MRI systems and related technologies intended to enhance patient outcomes and establish new care standards. The company is commercializing the first in-office MRI and robotic-guidance system using proprietary technologies.
For inquiries regarding partnerships, employment, or additional information, interested parties can reach Promaxo via their contact page or email hello@promaxo.com.